{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:17:34Z","timestamp":1784269054057,"version":"3.55.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Nocturnal blood pressure (BP) is superior to daytime BP in predicting cardiovascular mortality. It is of clinical relevance to evaluate the effect of esaxerenone combination therapy on nighttime BP in patients with uncontrolled hypertension.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A post hoc analysis of a multicenter, open-label, phase 3 study evaluated the nighttime BP-lowering effects of esaxerenone as monotherapy or in combination with a calcium channel blocker (CCB) or renin\u2013angiotensin system inhibitor (RASi) in Japanese patients with uncontrolled hypertension. In addition, the effect on N-terminal pro B-type natriuretic peptide (NT-proBNP), a known biomarker of cardiovascular disease prognosis, was evaluated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In total, 270 patients were included in this analysis (172, 49, and 49 patients in the monotherapy, CCB, and RASi groups, respectively). The 24-hour ambulatory systolic BP reduction from baseline was\u2005\u2212\u200510.0,\u2005\u2212\u20056.0, and\u2005\u2212\u200517.0 mm Hg in the monotherapy, CCB, and RASi groups, respectively. Nighttime systolic BP decreased significantly from baseline to week 28 in all groups (P\u2005&amp;lt;\u20050.001 each); the RASi group showed the greatest change (\u2212\u200520.6 mm Hg). NT-proBNP decreased significantly in all three treatment groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Esaxerenone when used in combination with a CCB or RASi, but especially when used in combination with a RASi, may be a useful treatment option for patients with uncontrolled hypertension to control nocturnal BP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ajh\/hpaf048","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T17:19:50Z","timestamp":1743441590000},"page":"605-611","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Esaxerenone Plus a Renin\u2013Angiotensin System Inhibitor or Calcium Channel Blocker for Nocturnal Hypertension: A Post Hoc Analysis"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8251-4480","authenticated-orcid":false,"given":"Kazuomi","family":"Kario","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine , Shimotsuke,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-3626","authenticated-orcid":false,"given":"Sadayoshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University School of Medicine , Sendai,","place":["Japan"]},{"name":"Katta General Hospital , Shiroishi,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2514-4919","authenticated-orcid":false,"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Nephrology, Keio University School of Medicine , Tokyo,","place":["Japan"]},{"name":"Center for Preventive Medicine, Keio University , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Rakugi","sequence":"additional","affiliation":[{"name":"Department of Geriatric and General Medicine, Osaka University Graduate School of Medicine , Suita,","place":["Japan"]},{"name":"Osaka Rosai Hospital, Japan Organization of Occupational Health and Safety , Sakai,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Okuda","sequence":"additional","affiliation":[{"name":"Data Intelligence Department, Global DX, Daiichi Sankyo Co., Ltd. , Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Yamakawa","sequence":"additional","affiliation":[{"name":"Development Planning Department, Development Function, R&D Division, Daiichi Sankyo Co., Ltd ., Tokyo,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"2025071501515103200_CIT0001","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/erc.09.35","article-title":"Dipping pattern of nocturnal blood pressure in patients with hypertension","volume":"7","author":"Fagard","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2025071501515103200_CIT0002","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/jch.13656","article-title":"Extreme dipping: more complex than it looks","volume":"21","author":"Cuspidi","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025071501515103200_CIT0003","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.HYP.27.1.130","article-title":"Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers","volume":"27","author":"Kario","year":"1996","journal-title":"Hypertension"},{"key":"2025071501515103200_CIT0004","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/hy1001.092640","article-title":"Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives","volume":"38","author":"Kario","year":"2001","journal-title":"Hypertension"},{"key":"2025071501515103200_CIT0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1081\/CEH-120028556","article-title":"Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure","volume":"26","author":"Kario","year":"2004","journal-title":"Clin Exp Hypertens"},{"key":"2025071501515103200_CIT0006","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","article-title":"Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study","volume":"20","author":"Ohkubo","year":"2002","journal-title":"J Hypertens"},{"key":"2025071501515103200_CIT0007","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/hr.2009.172","article-title":"Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study","volume":"33","author":"Guo","year":"2010","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0008","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(23)00733-X","article-title":"Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients","volume":"401","author":"Staplin","year":"2023","journal-title":"Lancet"},{"key":"2025071501515103200_CIT0009","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","article-title":"2023 ESH guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"2025071501515103200_CIT0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41440-022-01087-9","article-title":"Concept, study design, and baseline blood pressure control status of the nationwide prospective HI-JAMP study using multisensor ABPM","volume":"46","author":"Kario","year":"2023","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0011","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.120.049730","article-title":"Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study","volume":"142","author":"Kario","year":"2020","journal-title":"Circulation"},{"key":"2025071501515103200_CIT0012","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ajh\/hpaa155","article-title":"Effect of the nonsteroidal mineralocorticoid receptor blocker, esaxerenone, on nocturnal hypertension: a post hoc analysis of the ESAX-HTN study","volume":"34","author":"Kario","year":"2021","journal-title":"Am J Hypertens"},{"key":"2025071501515103200_CIT0013","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41440-021-00756-5","article-title":"Effect of esaxerenone on nocturnal blood pressure and natriuretic peptide in different dipping phenotypes","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0014","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2215\/CJN.07370713","article-title":"Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers","volume":"8","author":"Navaneethan","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025071501515103200_CIT0015","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/s41440-019-0314-7","article-title":"Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension","volume":"42","author":"Rakugi","year":"2019","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0016","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/jch.13652","article-title":"Expert panel consensus recommendations for ambulatory blood pressure monitoring in Asia: the HOPE Asia network","volume":"21","author":"Kario","year":"2019","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025071501515103200_CIT0017","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jch.13751","article-title":"2020 Consensus summary on the management of hypertension in Asia from the HOPE Asia Network","volume":"22","author":"Kario","year":"2020","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025071501515103200_CIT0018","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/hr.2010.47","article-title":"Salt sensitivity and circadian rhythm of blood pressure: the keys to connect CKD with cardiovascular events","volume":"33","author":"Kimura","year":"2010","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0019","doi-asserted-by":"crossref","first-page":"19","DOI":"10.30548\/vascfail.3.1_19","article-title":"The relationship between estimated salt intake and central systolic blood pressure in Japanese outpatients with hypertension","volume":"3","author":"Takahashi","year":"2019","journal-title":"Vascular Failure"},{"key":"2025071501515103200_CIT0020","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/2047487316683070","article-title":"Plasma NT-proBNP mirrors the deleterious cardiovascular and renal continuum in hypertension","volume":"24","author":"Courand","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"2025071501515103200_CIT0021","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jch.12321","article-title":"Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study","volume":"16","author":"Hoshide","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025071501515103200_CIT0022","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/jch.12500","article-title":"Sleep blood pressure self-measured at home as a novel determinant of organ damage: Japan morning surge home blood pressure (J-HOP) study","volume":"17","author":"Kario","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2025071501515103200_CIT0023","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/s41440-021-00667-5","article-title":"Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events","volume":"44","author":"Hoshide","year":"2021","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0024","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJMoa031994","article-title":"Plasma natriuretic peptide levels and the risk of cardiovascular events and death","volume":"350","author":"Wang","year":"2004","journal-title":"N Engl J Med"},{"key":"2025071501515103200_CIT0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1291\/hypres.26.521","article-title":"Salt sensitivity of Japanese from the viewpoint of gene polymorphism","volume":"26","author":"Katsuya","year":"2003","journal-title":"Hypertens Res"},{"key":"2025071501515103200_CIT0026","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/HYPERTENSIONAHA.111.00217","article-title":"Isolated nocturnal hypertension: a disease masked in the dark","volume":"61","author":"Li","year":"2013","journal-title":"Hypertension"},{"key":"2025071501515103200_CIT0027","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/HYPERTENSIONAHA.117.10238","article-title":"Consensus document on improving hypertension management in Asian patients, taking Into account Asian characteristics","volume":"71","author":"Kario","year":"2018","journal-title":"Hypertension"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/advance-article-pdf\/doi\/10.1093\/ajh\/hpaf048\/62852973\/hpaf048.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/8\/605\/62852973\/hpaf048.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/38\/8\/605\/62852973\/hpaf048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T05:52:01Z","timestamp":1752558721000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/38\/8\/605\/8104866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,5,26]]},"published-print":{"date-parts":[[2025,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpaf048","relation":{},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,5,26]]}}}